Rasburicase improves the outcome of acute kidney injury from typical hemolytic uremic syndrome.
Myung Hyun ChoYo Han AhnSeon Hee LimJi Hyun KimIl-Soo HaHae Il CheongHee Gyung KangPublished in: Pediatric nephrology (Berlin, Germany) (2020)
Children with typical HUS treated with rasburicase had shorter hospital stays and less long-term sequelae at 1-year post-discharge than those who were not treated with rasburicase. These results support the use of rasburicase to prevent CKD in pediatric patients with typical HUS-associated AKI. Graphical Abstract.